|
|
 |
|
Total Number of Holdings (excluding cash): 50
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$92,748.61 |
2.91% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$89,156.31 |
2.80% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$86,446.75 |
2.71% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$81,747.96 |
2.57% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$79,304.65 |
2.49% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$79,373.69 |
2.49% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$78,631.92 |
2.47% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$77,526.72 |
2.43% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$76,591.20 |
2.40% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$76,323.69 |
2.40% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$76,154.85 |
2.39% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$75,161.87 |
2.36% |
| Waters Corporation |
WAT |
941848103 |
184 |
$75,024.16 |
2.36% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$74,953.53 |
2.35% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$73,277.51 |
2.30% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$69,998.04 |
2.20% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$69,558.38 |
2.18% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$69,090.18 |
2.17% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$68,743.17 |
2.16% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$68,383.04 |
2.15% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$66,268.86 |
2.08% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$65,167.51 |
2.05% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$64,897.56 |
2.04% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$63,783.90 |
2.00% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$62,815.30 |
1.97% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$62,025.44 |
1.95% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$62,182.80 |
1.95% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$62,160.60 |
1.95% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$61,245.60 |
1.92% |
| Steris Plc |
STE |
G8473T100 |
265 |
$60,883.75 |
1.91% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$60,145.20 |
1.89% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$58,194.40 |
1.83% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$58,402.59 |
1.83% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$58,236.26 |
1.83% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$57,712.32 |
1.81% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$57,439.39 |
1.80% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$56,855.46 |
1.79% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$55,922.59 |
1.76% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$55,498.24 |
1.74% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$54,897.06 |
1.72% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$51,809.52 |
1.63% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$51,533.25 |
1.62% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$50,742.90 |
1.59% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$49,115.65 |
1.54% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$48,672.76 |
1.53% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$46,903.24 |
1.47% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$45,131.29 |
1.42% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$42,410.14 |
1.33% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$41,910.00 |
1.32% |
| US Dollar |
$USD |
|
13,565 |
$13,565.44 |
0.43% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|